Innophos Reports Net Sales of $209 Million in Q4
date:Feb 16, 2013
o level on lower market prices, but higher volumes.

Diluted EPS for the fourth quarter 2012 was $0.60 compared to $0.93 for the fourth quarter 2011. Included in the current quarter was $0.02 per share expense for accelerated deferred financing and interest rate premiums related to the senior credit facility refinanced in December 2012.

The fourth quarter 2011 results included a $0.05 per share benefit for changes in estimates on Mexican water duty charges and currency translation effects on t
2/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/14 02:23